FDA
approval
· 2019-07-09
FDA Approved: TELMISARTAN — Supplemental Application (Ascend Laboratories, LLC)
Summary
FDA approves a supplemental application for telmisartan from Ascend Laboratories, LLC, authorizing continued marketing of the generic ARB.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TELMISARTAN (TELMISARTAN)